LAMPERTICO, PIETRO
LAMPERTICO, PIETRO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study
2025 M. Iavarone, E. Alimenti, M. Puoti, H. Hasson, B. Monti, S. Bhoori, F. Peracchi, A. Siribelli, M. Fava, M. Bruccoleri, M. Merli, G. Morsica, A. De Silvestri, P. Bonfanti, A. Castagna, A. Soria, P. Lampertico
Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg‐IFNα‐2a as Treatment for Chronic Hepatitis Delta
2025 P. Lampertico, P.O. Bogomolov, V. Chulanov, T. Stepanova, V. Morozov, L. Allweiss, M. Dandri, J. Burhenne, A. Blank, S. Ciesek, C. Elsner, U. Dittmer, Q. An, D. Manuilov, B.L. Da, J.F. Flaherty, S. Urban, H. Wedemeyer
Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48
2025 T. Asselah, P. Lampertico, S. Aleman, M. Bourlière, A. Streinu-Cercel, P. Bogomolov, V. Morozov, T. Stepanova, S. Lazar, D. Manuilov, R. Mercier, S. Tseng, L. Ye, J.F. Flaherty, A. Osinusi, B.L. Da, G.M. Chee, A.H. Lau, M.R. Brunetto, H. Wedemeyer
Development and Validation of a PIVKA-II-Based Model for HCC Risk Stratification in Patients With HCV-Related Cirrhosis Successfully Treated With DAA
2025 G.P. Caviglia, P. Fariselli, R. D'Ambrosio, P. Colombatto, E. Degasperi, G. Ricco, M.L. Abate, G. Birolo, G. Troshina, F. Damone, B. Coco, D. Cavallone, R. Perbellini, S. Monico, G.M. Saracco, M.R. Brunetto, P. Lampertico, A. Ciancio
Modeling challenges of hepatitis D virus kinetics during bulevirtide-based therapy
2025 A. Mhlanga, O. Wasserman, P. Lampertico, S.J. Cotler, H. Dahari
Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtide
2025 M. Buti, H. Wedemeyer, S. Aleman, V. Chulanov, V. Morozov, O. Sagalova, T. Stepanova, R.G. Gish, A. Lloyd, A.M. Kaushik, V. Suri, D. Manuilov, A.O. Osinusi, J.F. Flaherty, P. Lampertico
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B
2025 M. Buti, J. Heo, Y. Tanaka, P. Andreone, M. Atsukawa, J. Cabezas, E. Chak, C.S. Coffin, K. Fujiwara, N. Gankina, S.C. Gordon, E. Janczewska, A. Komori, P. Lampertico, S. Mcpherson, V. Morozov, R. Plesniak, S. Poulin, P. Ryan, O. Sagalova, G. Sheng, N. Voloshina, Q. Xie, H.J. Yim, S. Dixon, M. Paff, L. Felton, M. Lee, T. Greene, J. Lim, D. Lakshminarayanan, G. Mcgonagle, H. Plein, A.S. Youssef, R. Elston, S. Kendrick, D. Theodore
Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter Study
2025 G. Caviglia, A. Ferro, R. D'Ambrosio, R. Perbellini, P. Lampertico, G. Periti, L. Valenti, C. Ciccioli, G. Pennisi, S. Petta, L. Brodosi, M. Petroni, F. Marchignoli, L. Pironi, A. Sagripanti, M. Argenziano, G. Svegliati-Baroni, C. Rosso, F. Barutta, A. Armandi, G. Gruden, E. Bugianesi
The impact of BCLC recommendations on survival for patients with hepatocellular carcinoma
2025 M. Iavarone, E. Alimenti, L. Canova, M. Bruccoleri, B. Antonelli, A.M. Ierardi, A. Sangiovanni, G. Cabibbo, A. De Silvestri, L. Caccamo, G. Carrafiello, P. Lampertico
High Rate of Antibody Response to Multiple Doses of the COVID-19 Vaccine in Liver Transplant Recipients: Analysis of Predictive Factors
2025 N. Zignani, A. Costantino, M. Sagasta, C. Dibenedetto, R. Perbellini, S.C. Uceda Renteria, P. Lampertico, M. Francesca Donato
Comparing methods for plasma HDV RNA quantification in bulevirtide-treated and untreated patients with HDV
2025 M.P. Anolli, S. Uceda Renteria, E. Degasperi, F. Facchetti, D. Sambarino, M. Borghi, R. Perbellini, R. Soffredini, S. Monico, A. Callegaro, P. Lampertico
Noninvasive Assessment of portal Hypertension in Patients With Primary Biliary Cholangitis is Affected by Severity of Cholestasis
2025 V. Calvaruso, C. Celsa, L. Cristoferi, M. Scaravaglio, R. Smith, S. Kaur, G. Di Maria, L. Capodicasa, G. Pennisi, A. Gerussi, E. Nofit, F. Malinverno, P. Lampertico, N. Cazzagon, M. Marzioni, U. Vespasiani-Gentilucci, F. Colapietro, P. Andreone, A.L. De Nalda, C. Rigamonti, M. Viganò, E.G. Giannini, M. Russello, E. Vanni, F. Cerini, A. Orlandini, M. Brunetto, G.A. Niro, G. Vettori, A. Castellaneta, V. Cardinale, D. Alvaro, A. Mega, V.P. Palitti, V. Cossiga, F. Morisco, F. Bellanti, L. Baiocchi, L. Fabris, M. Persico, E. Degasperi, S. Labanca, E. Bonaiuto, F. Pezzato, A. Federico, S. Petta, V. Di Marco, G.F. Mells, E. Culver, P. Invernizzi, C. Cammà, M. Carbone
COVID-19 Vaccine in Lung and Liver Transplant Recipients Exceeds Expectations: An Italian Real-Life Experience on Immunogenicity and Clinical Efficacy of BNT162b2 Vaccine
2024 L.C. Morlacchi, G. Alicandro, S. Uceda Renteria, N. Zignani, G. Giacomel, V. Rossetti, M. Sagasta, G. Citterio, A. Lombardi, C. Dibenedetto, B. Antonelli, L. Rosso, P. Lampertico, F. Ceriotti, F. Blasi, M.F. Donato
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration
2024 V. Rosato, R. Nevola, M. Dallio, P. Di Micco, A. Spinetti, L. Zeneli, A. Ciancio, M. Milella, P. Colombatto, G. D'Adamo, E. Rosselli Del Turco, P. Gallo, A. Falcomatà, S. De Nicola, N. Pugliese, R. D'Ambrosio, A. Soria, E. Colella, A. Federico, M. Brunetto, U. Vespasiani-Gentilucci, A. Aghemo, P. Lampertico, A. Izzi, D. Mastrocinque, E. Claar
HCC risk in patients who are HBeAg-positive and have chronic hepatitis B under long-term nucleos(t)ide analogue therapy: New insights from Asia
2024 G. Papatherodoridis, P. Lampertico
Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failure
2024 C. Graf, R. D'Ambrosio, E. Degasperi, S. Paolucci, J. Llaneras, J. Vermehren, G. Dultz, K. Peiffer, F. Finkelmeier, E. Herrmann, S. Zeuzem, M. Buti, P. Lampertico, J. Dietz, C. Sarrazin
Sodium taurocholate cotransporting polypeptide (NTCP) polymorphisms may influence HDV RNA load and early response to bulevirtide
2024 P. Toniutto, E. Falleti, S. Cmet, A. Cussigh, E. Degasperi, M.P. Anolli, D. Sambarino, F. Facchetti, M. Borghi, R. Perbellini, S. Monico, P. Lampertico
Incidence and Predictors of Esophagogastric Varices Bleeding in Patients with Hepatocellular Carcinoma in Lenvatinib
2024 M. Iavarone, E. Alimenti, T. Tada, S. Shimose, G. Suda, C. Yoo, C. Soldà, F. Piscaglia, G. Tosetti, F. Marra, C. Vivaldi, F. Conti, M. Schirripa, H. Iwamoto, T. Sho, S.H. Lee, M.D. Rizzato, M. Tonnini, M. Rimini, C. Campani, G. Masi, F. Foschi, M. Bruccoleri, T. Kawaguchi, T. Kumada, A. Hiraoka, M. Atsukawa, S. Fukunishi, T. Ishikawa, K. Tajiri, H. Ochi, S. Yasuda, H. Toyoda, T. Hatanaka, S. Kakizaki, K. Kawata, F. Tada, H. Ohama, N. Itokawa, T. Okubo, T. Arai, M. Imai, A. Naganuma, A. Casadei-Gardini, P. Lampertico
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
2024 D. Razavi-Shearer, H. Child, K. Razavi-Shearer, A. Voeller, H. Razavi, M. Buti, F. Tacke, N. Terrault, S. Zeuzem, Z. Abbas, A. Aghemo, U.S. Akarca, N. Al Masri, A. Alalwan, M.A. Blome, A. Jerkeman, S. Aleman, H. Kamal, A. Alghamdi, M. Alghamdi, S. Alghamdi, W. Al-Hamoudi, E. Ali, A. Aljumah, I. Altraif, J. Amarsanaa, T. Asselah, O. Baatarkhuu, A. Babameto, Z. Ben-Ari, T. Berg, M. Biondi, W. Braga, C. Brandao-Mello, R. Brown, M. Brunetto, J. Cabezas, M. Cardoso, A. Martins, H.L.Y. Chan, H. Cheinquer, C.-. Chen, H.-. Yang, P.-. Chen, C.-. Chien, W.-. Chuang, L.C. Garza, B. Coco, C. Coffin, N. Coppola, M. Cornberg, A. Craxi, J. Crespo, L. Cuko, V. De Ledinghen, A.-. Duberg, O. Etzion, M.L. Ferraz, P. Ferreira, X. Forns, G. Foster, J. Fung, G. Gaeta, J. Garcia-Samaniego, J. Genov, L. Gheorghe, P. Gholam, R. Gish, J. Glenn, S. Hamid, J. Hercun, Y.-. Hsu, C.-. Hu, J.-. Huang, R. Idilman, W. Jafri, N. Janjua, D. Jelev, J. Jia, M. Kaberg, K. Kaita, J.-. Kao, A. Khan, D.Y. Kim, L. Kondili, M. Lagging, P. Lampertico, P. Lazaro, J.V. Lazarus, M.-. Lee, Y.-. Lim, C. Lobato, G. Macedo, R. Marinho, P. Marotta, M.C. Mendes-Correa, N. Mendez-Sanchez, M.-. Navas, Q. Ning, N. Ormeci, M. Orrego, C. Osiowy, C. Pan, M. Pessoa, Z. Piracha, C. Pop, H. Qureshi, G. Raimondo, A. Ramji, S. Ribeiro, C. Rios-Hincapie, M. Rodriguez, W. Rosenberg, D. Roulot, S. Ryder, U. Saeed, R. Safadi, D. Shouval, F. Sanai, J.F. Sanchez-Avila, T. Santantonio, C. Sarrazin, W.-. Seto, M. Simonova, J. Tanaka, T. Tergast, O. Tsendsuren, C. Valente, J.M. Villalobos-Salcedo, Y. Waheed, G. Wong, V. Wong, T. Yip, J.-. Wu, M.-. Yu, M.-. Yuen, C. Yurdaydin, E. Zuckerman
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis—A real-world case series
2024 C. Dietz-Fricke, E. Degasperi, M. Jachs, B. Maasoumy, F.P. Reiter, A. Geier, J.M. Grottenthaler, C.P. Berg, K. Sprinzl, S. Zeuzem, J. Gödiker, B. Schlevogt, T. Herta, J. Wiegand, R. Soffredini, H. Wedemeyer, K. Deterding, T. Reiberger, P. Lampertico